$192 Million is the total value of AH Equity Partners Bio II, L.L.C.'s 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | EQRx, Inc. | $118,930 | – | 17,438,465 | +100.0% | 61.93% | – | |
| New | Erasca, Inc. | $38,950 | – | 2,500,000 | +100.0% | 20.28% | – | |
| NVTA | New | InVitae Corporation | $17,868 | – | 1,170,127 | +100.0% | 9.30% | – |
| NAUT | New | Nautilus Biotechnology, Inc. | $16,298 | – | 16,298,006 | +100.0% | 8.49% | – |
Source
Signed by
- Scott Kupor — Chief Operating Officer
- AH Equity Partners Bio II, L.L.C. insiders transactions
- AH Equity Partners Bio II, L.L.C. filings
- Similar filers BETA
Export AH Equity Partners Bio II, L.L.C.'s holdings